Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Urinary bladder neoplasms; Cystectomy; Patient readmission; Rural health;
مقالات ISI سرطان مثانه یا نئوپلاسم مثانه ادرار (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; urinary bladder fistula; cystectomy; urinary diversion; risk factors; BMI; body mass index; CCI; Charlson comorbidity index; ONB; orthotopic neobladder; RC; radical cystectomy; RT; radiation therapy; SBA; small bowel anastomosis
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Urinary bladder; Urinary bladder neoplasms; Cystoscopy; Image interpretation, Computer-assisted; early detection of cancer; Endoscopy;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Hematuria; Diagnosis; Urinary bladder neoplasms; Electronic health records; Safety;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; health care costs; patient outcome assessment; quality of life; surveys and questionnaires; COST; Comprehensive Score for Financial Toxicity; FACT; Functional Assessment of Cancer Therapy; FACT-GP; FACT-General Population; FT; f
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; hematuria; pathology; molecular; RNA; messenger; early detection of cancer; ABL1; ABL proto-oncogene 1; ANXA10; annexin 10; BCa; bladder cancer; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CRH; corticotropin releasin
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Bladder cancer; Urothelial carcinoma; Urinary bladder neoplasms; Cystectomy; Diet; Healthy diet; Quality of life; Health-related quality of life; Cancer survivors; Surveys and questionnaires; Vitamins; Vitamin D; Whole grains; Cross-sectional studies;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; urothelium; urologic neoplasms; drug therapy; combination; mortality; BCa; bladder cancer; EORTC; European Organization for the Research and Treatment of Cancer; GC; gemcitabine and cisplatin; HD; high dose; MCAVI; methotrexate,
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; United States; Epidemiology; Urinary bladder neoplasms; Healthcare disparities; Therapeutics; Cystectomy; Survival;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Bladder cancer; Radical cystectomy; Treatment; Travel distance; Access to care; Readmissions; Urinary bladder neoplasms;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; cystectomy; venous thromboembolism; heparin; low-molecular-weight; AUA; American Urological Association; CrCl; creatinine clearance; DVT; deep venous thrombosis; EAU; European Association of Urology; ERAS®; enhanced recovery af
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; neoplasm invasiveness; neoplasm recurrence; local; BCG vaccine; mortality; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CR; complete response; DSS; disease specific survival; MIBC; muscle invasive bladder cancer; NMIB
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Health care disparities; Health care; Urinary bladder neoplasms; Cystectomy;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; cystectomy; mortality; female; male; CSS; cancer specific survival; DFS; disease-free survival; OS; overall survival; UCB; urothelial bladder cancer;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; carcinoma; programmed cell death 1 receptor; immunotherapy; APC; antigen-presenting cell; BCG; bacillus Calmette-Guérin; CD; cluster of differentiation; CR; complete response; CTLA-4; cytotoxic T-lymphocyte-associated antigen-4
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; neoplasm invasiveness; drug therapy; cystectomy; delivery of health care; DS; definitive surgery; MIBC; muscle invasive bladder cancer; NAC; neoadjuvant chemotherapy; NCDB; National Cancer Database; Q; quartile; SC; systemic che
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; cystectomy; time-to-treatment; quality improvement; EMR; electronic medical record; NAC; neoadjuvant chemotherapy; RC; radical cystectomy; TURBT; transurethral resection of bladder tumor;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; in situ hybridization; fluorescence; biomarker; tumor; nuclear matrix protein 22; bladder tumor-associated antigen; ACM; all cause mortality; BTA; bladder tumor antigen; CSM; cancer specific mortality; FISH; fluorescence in situ
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Neoplasms by histologic type; Propensity score; Surgical pathology; Survival; Urinary bladder neoplasms;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Urinary bladder neoplasms; Hematuria; Therapeutic embolisation;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; laparoscopic surgery; recurrence; renal pelvis; transitional cell carcinoma; ureter; urinary bladder neoplasms;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Urinary bladder neoplasms; Cystectomy; Radiotherapy; Drug therapy; Propensity score; Survival;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Urinary bladder neoplasms; Epithelioid angiosarcoma; Postirradiation-associated sarcoma;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Bladder augmentation; Bladder rupture; Urinary bladder neoplasms; Chronic renal failure; Obesity;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; CIS; carcinoma in situ; RNU; radical nephroureterectomy; UTUC; upper tract urothelial carcinoma; Urological neoplasms; Transitional cell carcinoma; Ureteric neoplasms; Urinary bladder neoplasms; Intravesical recurrence;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Statins; Outcome; Urinary bladder neoplasms;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Cystectomy; Health care quality, access, and evaluation; Travel; Urinary bladder neoplasms; Healthcare market;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Cystectomy; Frail elderly; Outcome assessment; Patient discharge; Urinary bladder neoplasms;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Cystectomy; Functional outcomes; Outcomes assessment; Urinary bladder neoplasms; Gender disparities;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Urinary bladder neoplasms; Urologic neoplasms; Diagnostic techniques; Urological; Molecular diagnostic techniques; Biomarkers;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; High volume; Postoperative complications; Quality of health care; Urinary bladder neoplasms; Volume-outcome relationship;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Cystectomy; Erectile dysfunction; Urinary bladder neoplasms; Urinary incontinence;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; neoplasm recurrence; local; diagnostic techniques; urological; molecular diagnostic techniques; biomarkers; tumor; BCG; bacillus Calmette-Guérin; EORTC; European Organisation for Research and Treatment of Cancer; NPV; negative
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; cystoscopy; aminolevulinic acid; photochemotherapy; drug-related side effects and adverse reactions; AE; adverse event; BLC; blue light cystoscopy; CIS; carcinoma in situ; CTCAE; Common Terminology Criteria for Adverse Events; F
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; neoplasm recurrence; local; robotic surgical procedures; cystectomy; treatment failure; ASA®; American Society of Anesthesiologists®; DSS; disease specific survival; EOF; early oncologic failure; IRCC; International Robotic Cy
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; cystectomy; stents; nephrostomy; percutaneous; neoplasm recurrence; local; BC; bladder cancer; CIS; carcinoma in situ; CSS; cancer specific survival; CT; computerized tomography; IVP; excretory urography; RC; radical cystectomy;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; cystectomy; length of stay; perioperative care; urinary bladder diseases; urinary bladder neoplasms; ACS NSQIP®; American College of Surgeons National Surgical Quality Improvement Program; ASA®; American Society of Anesthesiologists®; BBC; benign bladd
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; cystectomy; patient readmission; postoperative care; continuity of patient care; NRD; Nationwide Readmissions Database; RC; radical cystectomy;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; administration; intravesical; BCG vaccine; mitomycin; interferons; BCG; bacillus Calmette-Guérin; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; SOE; strength of evidence; TURBT; transurethral bladder tumor resecti
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; fluorescence; cystoscopy; aminolevulinic acid; urinary bladder neoplasms; 5-ALA; 5-aminolevulinic acid; HAL; hexaminolevulinic acid; NMIBC; nonmuscle invasive bladder cancer; RCT; randomized, controlled trial; SOE; strength of evidence; TURBT; transurethr
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; Urinary bladder neoplasms; Diffusion magnetic resonance imaging; Biological markers; Carcinoma, transitional cells; Reference standards;
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; ureter; urinary bladder neoplasms; carcinoma; constriction, pathologic; recurrenceBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CTU, computerized tomography urography; IMPDU, intramural portion of distal ureter; MMC, mitomycin C; NMIBC, nonmuscle
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; patient readmission; urinary bladder neoplasms; cystectomy; complications; treatment outcomesCCI, Charlson comorbidity index; LOS, length of stay; RC, radical cystectomy; SNF, skilled nursing facility; VTE, venous thromboembolic event
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; recurrence; disease progression; Mycobacterium bovis; mitomycinBC, bladder cancer; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CS, conditional survival; NMIBC, nonmuscle invasive BC; TURB, transurethral resection of b
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder; urinary bladder neoplasms; administration; intravesical; drug therapy; quality improvementBC, bladder cancer; NMIBC, nonmuscle invasive BC; IVC, intravesical chemotherapy; TURBT, transurethral bladder tumor resection; MMC, mitomycin C; QI
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; drug therapy; neoplasm recurrence; local; guideline adherence; practice patterns; physicians'; IPIOC; immediate postoperative instillation of chemotherapy; NMIBC; nonmuscle invasive bladder cancer; TUR; transurethral resection
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; neoadjuvant therapy; cystectomy; time factorsGC, gemcitabine and cisplatin; MIBC, muscle invasive bladder cancer; MVAC, methotrexate, vinblastine, doxorubicin and cisplatin; NAC, neoadjuvant chemotherapy; OS, overall survival; R
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; itraconazole; antifungal agents; risk; cystectomyTHIN, The Health Improvement Network
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; hematuria; epigenomics; diagnosis; riskBCa, bladder cancer; MSP, methylation specific PCR; NPV, negative predictive value; PCR, polymerase chain reaction
Keywords: سرطان مثانه یا نئوپلاسم مثانه ادرار; urinary bladder neoplasms; cystectomy; neoplasm recurrence; local; patient selection; morbidity; BCa; bladder cancer; BCG; bacillus Calmette-Guérin; CG; Clavien grade; CIS; carcinoma in situ; DSS; disease specific survival; LVI; lymphovascular invasion;